Breaking News
Get 40% Off 0
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March. Read full update
Close

HBM Healthcare Investments (HBMN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
197.40 +6.60    +3.46%
07/05 - Closed. Currency in CHF ( Disclaimer )
  • Volume: 6,395
  • Bid/Ask: 197.00 / 197.60
  • Day's Range: 195.00 - 199.00
Type:  Equity
Market:  Switzerland
ISIN:  CH0012627250 
VALOR:  1262725
HBM Healthcare Investments 197.40 +6.60 +3.46%

HBMN Recent Sentiments

 
This page features our users' sentiments regarding the HBM Healthcare Investments stock. They are displayed on both charts of different time periods and in a detailed table.
Start Date Username Call Open Rate End Date Chg. %
Aug 22, 2023 angelo rolando   181.80 Nov 30, 2023 @ 174.60 +3.96%
Aug 17, 2023 Tim Kägi   194.60 Sep 27, 2023 @ 175.80 -9.66%
Jul 17, 2023 roland maenhout   197.40 Nov 30, 2023 @ 174.60 -11.55%
May 30, 2023 Adrian Nyffeler   201.50 Jul 17, 2023 @ 197.40 -2.03%
Dec 16, 2022 angelo rolando   209.00 Jan 06, 2023 @ 205.00 +1.91%
Dec 13, 2022 Adrian Nyffeler   227.00 Dec 19, 2022 @ 206.00 -9.25%
Oct 13, 2022 Giuliano Nardoni   219.50 Nov 04, 2022 @ 226.00 +2.96%
Jul 12, 2022 Adrian Nyffeler   267.00 Aug 05, 2022 @ 261.00 -2.25%
Apr 27, 2022 Giuliano Nardoni   238.00 May 20, 2022 @ 252.50 -6.09%
Apr 27, 2022 Giuliano Nardoni   249.00 Apr 27, 2022 @ 240.50 +3.41%
Apr 04, 2022 roland maenhout   260.50 Apr 29, 2022 @ 235.00 -9.79%
Jan 19, 2022 Gabriel Dev   294.00 Jan 24, 2022 @ 277.00 -5.78%
Nov 24, 2021 Francesco Lama   345.00 Dec 17, 2021 @ 342.00 -0.87%
Aug 31, 2021 Wolfram Eckstein   351.00 Sep 24, 2021 @ 349.00 -0.57%
May 03, 2021 massimo piazzalunga   335.50 May 28, 2021 @ 341.00 +1.64%
Feb 24, 2021 Alma Guerrera   337.50 Mar 05, 2021 @ 338.00 +0.15%
Jan 20, 2021 Paul Vercruysse   308.00 Feb 12, 2021 @ 351.00 +13.96%
Jan 08, 2021 Dudi Schifter   307.00 Jan 29, 2021 @ 303.50 -1.14%
Dec 18, 2020 Matteo Petrini   297.00 Jan 08, 2021 @ 305.50 +2.86%
Dec 17, 2020 massimo piazzalunga   293.50 Jan 08, 2021 @ 305.50 +4.09%
Nov 23, 2020 Serge Widmer   287.50 Dec 18, 2020 @ 294.00 +2.26%
Sep 22, 2020 Giuseppe Marcello   278.00 Oct 16, 2020 @ 271.50 -2.34%
Sep 04, 2020 Bob Fink   276.50 Sep 25, 2020 @ 266.00 -3.80%
Aug 27, 2020 Abe Abraham   280.00 Sep 18, 2020 @ 278.50 -0.54%
Jun 10, 2020 Bertie Brooks   232.00 Jul 03, 2020 @ 242.50 +4.53%
May 07, 2020 Eloah StClair   215.50 May 29, 2020 @ 245.00 +13.69%
Apr 30, 2020 Kurt Höltschi   219.00 May 22, 2020 @ 230.00 +5.02%
Apr 27, 2020 Florian Butler   216.50 May 22, 2020 @ 230.00 +6.24%
Mar 23, 2020 Bob Fink   163.00 Apr 17, 2020 @ 205.00 +25.77%
Mar 18, 2020 Simone Calcinai   169.40 Apr 09, 2020 @ 199.20 +17.59%
Mar 18, 2020 Simone Calcinai   169.40 Mar 18, 2020 @ 169.40 0.00%
Nov 28, 2019 Kurt Höltschi   212.00 Dec 12, 2019 @ 222.00 +4.72%
Nov 04, 2019 Dorien De Ridder   199.20 Nov 29, 2019 @ 215.00 +7.93%
Oct 10, 2019 Simone Calcinai   191.60 Oct 11, 2019 @ 191.20 -0.21%
Sep 26, 2019 Quentin Georges   193.20 Oct 18, 2019 @ 193.20 0.00%
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

HBMN Comments

Write your thoughts about HBM Healthcare Investments
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email